Priority Review Granted to Novel Pneumococcal Conjugate Vaccine V114
The V114 vaccine candidate consists of pneumococcal polysaccharides from 15 serotypes, including serotypes 22F and 33F, which are associated with invasive pneumococcal disease.
Pneumonia
Cadmium Burden Linked to Mortality From Influenza, Pneumonia
Risk for related mortality increased with urinary cadmium in the 80th versus the 20th percentile in whole population, never smokers in NHANES-III
Pneumococcal Colonization Exacerbated by Influenza-Like Illness
Researchers investigated the effects of ILI on pneumococcal carriage in community-dwelling older adults.
How Effective Is the Pneumococcal Vaccine PPSV223 in Adults?
The incidence of invasive pneumococcal disease (IPD) in adults has decreased considerably over the past few decades.
Inappropriate Antibiotic Use in Children With Community-Acquired Pneumonia
Study authors described the prescribing patterns in children with community-acquired pneumonia, and assessed the relationship between narrow-spectrum antibiotics, broad-spectrum antibiotics, and macrolides with clinical outcomes.
Appropriate Antimicrobial Therapy for A baumannii Lowers Mortality in Severely Ill Patients
The effect of appropriate antimicrobial therapy on 14-day mortality in patients severely ill with Acinetobacter baumannii bacteremic pneumonia was assessed, taking risk factors, patient demographics, and clinical characteristics into account.
COVID-19 With Suspected PE Shows Lung Changes Similar to Infarct, Organizing Pneumonia
Although hypercoagulability has been reported in critically ill patients with COVID-19, results from a small study revealed that these patients did not have a higher prevalence of pulmonary embolism compared to patients without COVID-19.
Novel Pneumococcal Conjugate Vaccine Immunogenic in Phase 3 Trials
Results from PNEU-PATH demonstrated comparable immune responses following vaccination with Pneumovax 23 in both treatment groups for the 15 serotypes in V114.
Discussing Influenza and Pneumococcal Vaccines With Patients During COVID-19
How should physicians be discussing influenza and pneumococcal vaccines with patients amidst the continuing COVID-19 pandemic?
S Aureus ICU Pneumonia Risk Higher When Patients Are Colonized at Admission
Approximately 7% of pneumonia cases acquired in the intensive care unit can be classified as Staphylococcus aureus intensive care unit pneumonia.
-
Loading...
-
Loading...
Next post in Pneumonia
